Almirall SA Share Price CBOE EUROPE EQUITIES
Equities
ES0157097017
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- EUR | - |
13/05 | Global markets live: Pfizer, Chevron, Amazon, Booking, Apple, Novavax, SoftBank... | |
13/05 | Almirall confirms full-year targets despite higher first-quarter costs | RE |
Sales 2024 * | 980M 1.07B 88.72B | Sales 2025 * | 1.08B 1.17B 97.76B | Capitalization | 1.94B 2.11B 176B |
---|---|---|---|---|---|
Net income 2024 * | 24M 26.08M 2.17B | Net income 2025 * | 63M 68.46M 5.7B | EV / Sales 2024 * | 1.98 x |
Net cash position 2024 * | 2.34M 2.55M 212M | Net cash position 2025 * | 77.1M 83.79M 6.98B | EV / Sales 2025 * | 1.73 x |
P/E ratio 2024 * |
77.2
x | P/E ratio 2025 * |
29.8
x | Employees | - |
Yield 2024 * |
2.02% | Yield 2025 * |
2% | Free-Float | 34.06% |
Latest transcript on Almirall SA
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 25/14/25 | |
Director of Finance/CFO | 54 | 11/19/11 | |
Karl Ziegelbauer
CTO | Chief Tech/Sci/R&D Officer | - | 07/21/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Seth J. Orlow
BRD | Director/Board Member | - | 01/16/01 |
Eva-Lotta Allan
BRD | Director/Board Member | 65 | 01/20/01 |
Director/Board Member | 65 | 01/19/01 |
1st Jan change | Capi. | |
---|---|---|
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |